ImmunoPrecise Antibodies ... (IPA)
NASDAQ: IPA
· Real-Time Price · USD
2.65
-0.10 (-3.64%)
At close: Aug 27, 2025, 3:59 PM
2.61
-1.51%
After-hours: Aug 27, 2025, 07:30 PM EDT
ImmunoPrecise Antibodies Cash Flow Statement
Financials in CAD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Aug 9, 2023 | Apr 30, 2023 | Jan 31, 2023 | Dec 13, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Net Income | -30.23M | -46.12M | -27.54M | -27.61M | -32.99M | -20.08M | -21.84M | -26.56M | -26.56M | -26.07M | -25.2M | -22.86M | -16.71M | -17.1M | -14.57M | -10.02M | -7.34M | -3.25M | -2.58M | -3.48M |
Depreciation & Amortization | 5.11M | 5.78M | 5.69M | 5.64M | 5.79M | 6.2M | 6.57M | 6.68M | 6.68M | 5.63M | 4.89M | 4.36M | 3.77M | 3.73M | 3.72M | 3.76M | 3.71M | 4.26M | 3.93M | 3.62M |
Stock-Based Compensation | 445K | 629K | 1.56M | 2.52M | 3.18M | 3.58M | 2.77M | 2.01M | 1.94M | 2.09M | 2.39M | 2.73M | 3.08M | 3.62M | 3.98M | 3.77M | 2.75M | 1.52M | 812.74K | 550.29K |
Other Working Capital | -76K | -156K | -330K | 246K | -2.46M | -2.57M | -2.68M | -3.7M | -976K | 66K | -2.6M | -1.29M | -1.09M | -2.79M | -511.65K | -1.16M | -810.29K | -152.98K | 511.43K | -242.38K |
Other Non-Cash Items | 21.81M | 21.35M | 264K | 108K | -65K | 2.41M | 2.47M | 2.3M | 2.3M | 119K | -329K | 80K | -310K | 768.04K | 1.16M | 762.92K | 1.27M | 39.27K | 212.49K | 649.36K |
Deferred Income Tax | -3.94M | -5.13M | -2.33M | -2.2M | -1.82M | -877K | -969K | -926K | -926K | -1.6M | -497K | -502K | -336K | 796.98K | -146K | -178K | 27.93K | -675.63K | -461.49K | -289.09K |
Change in Working Capital | 766K | 1M | 1.18M | 2.83M | -1.24M | -3.02M | -4.45M | -3.28M | -3.28M | 447K | -2.25M | -3.08M | 582K | -685.6K | 1.42M | -62.43K | -1.02M | -1.29M | -637.39K | -1.78M |
Operating Cash Flow | -6.41M | -7.91M | -7.38M | -5.37M | -13.86M | -13.45M | -16.33M | -19.83M | -19.83M | -19.39M | -21M | -19.27M | -9.92M | -8.87M | -4.43M | -1.97M | -600K | 595.17K | 1.27M | -739.4K |
Capital Expenditures | -799K | -1.57M | -1.29M | -1.52M | -1.35M | -685K | -1.09M | -1.5M | -1.5M | -1.37M | -1.59M | -1.01M | -1.26M | -1.23M | -1.13M | -1.74M | -1.43M | -1.16M | -1.06M | -525.74K |
Cash Acquisitions | n/a | n/a | n/a | n/a | -146K | -128K | -128K | -738K | -592K | -4.3M | -4.3M | -3.69M | -3.69M | -510.47K | -510.47K | -510.47K | -1.03M | -518.1K | -1.53M | -1.53M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 549K | 549K | 549K | 549K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | 36K | 121K | 121K | 140K | 165K | 80K | 80K | 61K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 99K | 115K | 7K | -141K | -80K | -96K | 31K | -429K | -490K | -558K | -768K | -259K | -259K | 79K | 279K | 21K | n/a | -214.28K | -1.23M | -1.03M |
Investing Cash Flow | -799K | -1.55M | -1.38M | -1.63M | -1.46M | -788K | -1.07M | -1.97M | -1.97M | -5.62M | -6.05M | -4.96M | -5.21M | -1.93M | -1.64M | -2.25M | -2.46M | -1.68M | -2.59M | -2.05M |
Debt Repayment | 1.61M | 1.75M | 1.58M | 1.27M | -1.34M | -1.42M | -1.48M | -1.47M | -1.34M | -1.22M | -1.07M | -997K | -962K | -950.67K | -849.67K | -926.67K | -771.67K | -420.4K | -328.22K | -274K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.07M | 2.07M | 2.07M | n/a | n/a | n/a | n/a | n/a | n/a | -5K | 181K | 181K | 207K | 212K | 26K | 25.64K | 3.65M | 3.65M | 3.65M | 3.65M |
Financial Cash Flow | 14.89M | 16.43M | 6.5M | 4.12M | 1.27M | -230K | -1.13M | -621K | -621K | 2.82M | 3.05M | 2.94M | 2.88M | 28.57M | 28.71M | 39.6M | 43.38M | 15.21M | 15.07M | 3.85M |
Net Cash Flow | 7.25M | 6.72M | -2.48M | -2.81M | -13.99M | -14.29M | -18.21M | -21.68M | -21.68M | -21.66M | -23.29M | -21.46M | -11.79M | 17.27M | 21.51M | 34.63M | 39.15M | 13.8M | 13.93M | 1.16M |
Free Cash Flow | -7.21M | -9.48M | -8.67M | -6.89M | -15.21M | -14.13M | -17.42M | -21.33M | -21.33M | -20.75M | -22.59M | -20.28M | -11.18M | -10.1M | -5.56M | -3.71M | -2.03M | -562.23K | 209.3K | -1.27M |